Tumorboard- und Pathwayadhärenz am Comprehensive Cancer Center Freiburg (CCCF) eine Querschnittsstudie
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | German |
| Veröffentlicht: |
Freiburg im Breisgau
[2021]
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis Inhaltsverzeichnis |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV047453206 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t| | ||
| 008 | 210903s2021 gw a||| m||| 00||| ger d | ||
| 015 | |a 21,H06 |2 dnb | ||
| 016 | 7 | |a 1230583319 |2 DE-101 | |
| 020 | |c Broschur | ||
| 035 | |a (OCoLC)1238012219 | ||
| 035 | |a (DE-599)KXP1749111748 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a ger | |
| 044 | |a gw |c XA-DE-BW | ||
| 049 | |a DE-355 | ||
| 084 | |a 610 |2 sdnb | ||
| 084 | |8 1\p |a 616.994 |2 23ksdnb | ||
| 084 | |a 610 |2 23sdnb | ||
| 100 | 1 | |a Fricke, Mareike Ida Johanna |e Verfasser |0 (DE-588)1227903170 |4 aut | |
| 245 | 1 | 0 | |a Tumorboard- und Pathwayadhärenz am Comprehensive Cancer Center Freiburg (CCCF) |b eine Querschnittsstudie |c vorgelegt 2020 von Mareike Ida Johanna Fricke |
| 264 | 1 | |a Freiburg im Breisgau |c [2021] | |
| 300 | |a IV, 179 Seiten |b Illustrationen, Diagramme |c 30 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c Albert-Ludwigs-Universität Freiburg im Breigau |d 2021 | ||
| 650 | 0 | 7 | |8 2\p |a Tuberkulose |0 (DE-588)4130621-1 |2 gnd |
| 650 | 0 | 7 | |8 3\p |a Mastdarmkrebs |0 (DE-588)4169067-9 |2 gnd |
| 650 | 0 | 7 | |8 4\p |a Dickdarmkrebs |0 (DE-588)4012122-7 |2 gnd |
| 650 | 0 | 7 | |8 5\p |a Krebsregister |0 (DE-588)4123573-3 |2 gnd |
| 650 | 0 | 7 | |8 6\p |a Colonkrebs |0 (DE-588)4148225-6 |2 gnd |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 856 | 4 | 2 | |m B:DE-101 |q application/pdf |u https://d-nb.info/1230583319/04 |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032855150&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 883 | 2 | |8 1\p |a dnb |d 20210504 |q DE-101 |u https://d-nb.info/provenance/plan#dnb | |
| 883 | 0 | |8 2\p |a aepgnd |c 0,06062 |d 20210419 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 3\p |a aepgnd |c 0,02248 |d 20210419 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 4\p |a aepgnd |c 0,02082 |d 20210419 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 5\p |a aepgnd |c 0,02009 |d 20210419 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 6\p |a aepgnd |c 0,01838 |d 20210419 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-032855150 | |
Datensatz im Suchindex
| _version_ | 1819621051945975808 |
|---|---|
| adam_text | INHALTSVERZEICHNIS
ABKUERZUNGSVERZEICHNIS
...........................................................................................
III
1
EINLEITUNG
............................................................................................................
1
1.1
KOLOREKTALES
KARZINOM
..................................................................................
1
1.1.1
EPIDEMIOLOGIE.........................................................................................
1
1.1.2
AETIOLOGIE
.................................................................................................
1
1.1.3
PATHOGENESE
..........................................................................................
1
1.1.4
KLINISCHE
AUSPRAEGUNG
............................................................................
2
1.1.5
DIAGNOSTIK
..............................................................................................
2
1.1.6
TNM
UND
STADIEN
.............
...,3
1.1.7
THERAPIE
.................................................................................................
5
KOLONKARZINOM
......................................................................................................
6
REKTUMKARZINOM
...................................................................................................
7
1.1.8
KLINISCHE
PFADE
(CLINICAL
PATHWAYS)
DES
UNIKLINIKUMS
FREIBURG
.............
8
1.2
ONKOLOGISCHE
VERSORGUNG
IN
DEUTSCHLAND
...................................................
11
1.2.1
GESUNDHEITSPOLITISCHE
UND
WISSENSCHAFTLICHE
AKTIVITAETEN
......................
11
1.2.2
KREBSREGISTRIERUNG
UND
SEINE
ROLLE
IM
QUALITAETSMANAGEMENT
...............
12
1.2.3
KREBSZENTREN
UND
DEREN
ZERTIFIZIERUNGEN
.............................................
13
1.2.4
MULTIDISZIPLINAERE
TUMORBOARDS
.............................................................
13
1.3
ZIELE
DIESER
ARBEIT
........................................................................................
14
2
METHODIK
............................................................................................................
17
2.1
STUDIENDESIGN
UND
SETTING
...........................................................................
17
2.2
STUDIENTEILNEHMER
.......................................................................................
17
2.2.1
PATIENTENREKRUITIERUNG
..........................................................................
17
2.2.2
STUDIENEINSCHLUSS
................................................................................
18
2.2.3
AUSSCHLUSSKRITERIEN
..............................................................................
18
2.3
DATENERFASSUNG
...........................................................................................
19
2.4
STICHPROBENUMFANG
.....................................................................................
19
2.5
DATENEXTRAKTION
UND
ANALYSE
......................................................................
19
2.6
AUSWERTUNG
.................................................................................................
28
3
ERGEBNISSE
........................................................................................................
35
3.1
CHARAKTERISTIK
DER
TB
BESCHLUESSE
.................................................................
35
II
3.1.1
BESCHLUSSART
........................................................................................
35
3.1.2
VERTEILUNG
NACH
TUMORENTITAETEN
...........................................................
36
3.2
TUMORBOARDADHAERENZ
..................................................................................
37
3.2.1
FEHLENDE
TB
ADHAERENZ
........................................................................
39
3.2.2
FEHLENDE
TB
ADHAERENZ
AUS
MEDIZINISCHEN
GRUENDEN...........................
40
3.2.3
FEHLENDE
TB
ADHAERENZ
AUFGRUND
DES
PATIENTENWUNSCHES
....................
42
3.3
PATHWAYABDECKUNG
.....................................................................................
42
3.3.1
FEHLENDE
PATHWAYABDECKUNG
..............................................................
43
3.4
PATHWAYADHAERENZ
.......................................................................................
44
3.4.1
FEHLENDE
PATHWAYADHAERENZ.................................................................
45
3.5
CP
KNOTENPUNKTE
........................................................................................
45
3.5.1
HAEUFUNGEN
FEHLENDER
CP
ADHAERENZ
......................................................
45
3.5.2
FOKUS
AUF
AUSGEWAEHLTE
KNOTENPUNKTE
................................................
46
4
DISKUSSION
.........................................................................................................
53
4.1
THERAPEUTISCHE
FRAGESTELLUNGEN
ALS
HAUPTVORSTELLUNGSGRUND
....................
53
4.2
HOHE
TUMORBOARD-ADHAERENZ.......................................................................
53
4.3
SEHR
GUTE
PATHWAY-ADHAERENZ
.....................................................................
54
4.4
GRUENDE
FUER
FEHLENDE
TUMORBOARDADHAERENZ
................................................
55
4.5
LIMITIERUNGEN
..............................................................................................
56
4.6
AUSBLICK
......................................................................................................
56
4.7
SCHLUSSFOLGERUNGEN.....................................................................................
57
5
ZUSAMMENFASSUNG
..........................................................................................
59
6
LITERATURVERZEICHNIS
.........................................................................................
61
7
ANHANG
...............................................................................................................
65
7.1
EXCEL
TABELLE
..............................................................................................
65
7.2
LEBENSLAUF
.................................................................................................
177
7.3
EIDESSTATTLICHE
VERSICHERUNG
.....................................................................
178
7.4
DANKSAGUNG...............................................................................................
179
|
| any_adam_object | 1 |
| author | Fricke, Mareike Ida Johanna |
| author_GND | (DE-588)1227903170 |
| author_facet | Fricke, Mareike Ida Johanna |
| author_role | aut |
| author_sort | Fricke, Mareike Ida Johanna |
| author_variant | m i j f mij mijf |
| building | Verbundindex |
| bvnumber | BV047453206 |
| ctrlnum | (OCoLC)1238012219 (DE-599)KXP1749111748 |
| discipline | Medizin |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02371nam a2200505 c 4500</leader><controlfield tag="001">BV047453206</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">210903s2021 gw a||| m||| 00||| ger d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">21,H06</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1230583319</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="c">Broschur</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1238012219</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KXP1749111748</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BW</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.994</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fricke, Mareike Ida Johanna</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1227903170</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Tumorboard- und Pathwayadhärenz am Comprehensive Cancer Center Freiburg (CCCF)</subfield><subfield code="b">eine Querschnittsstudie</subfield><subfield code="c">vorgelegt 2020 von Mareike Ida Johanna Fricke</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Freiburg im Breisgau</subfield><subfield code="c">[2021]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IV, 179 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">30 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Albert-Ludwigs-Universität Freiburg im Breigau</subfield><subfield code="d">2021</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">2\p</subfield><subfield code="a">Tuberkulose</subfield><subfield code="0">(DE-588)4130621-1</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">3\p</subfield><subfield code="a">Mastdarmkrebs</subfield><subfield code="0">(DE-588)4169067-9</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">4\p</subfield><subfield code="a">Dickdarmkrebs</subfield><subfield code="0">(DE-588)4012122-7</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">5\p</subfield><subfield code="a">Krebsregister</subfield><subfield code="0">(DE-588)4123573-3</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">6\p</subfield><subfield code="a">Colonkrebs</subfield><subfield code="0">(DE-588)4148225-6</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">https://d-nb.info/1230583319/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032855150&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="883" ind1="2" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">dnb</subfield><subfield code="d">20210504</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#dnb</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,06062</subfield><subfield code="d">20210419</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,02248</subfield><subfield code="d">20210419</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,02082</subfield><subfield code="d">20210419</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">5\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,02009</subfield><subfield code="d">20210419</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">6\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,01838</subfield><subfield code="d">20210419</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032855150</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV047453206 |
| illustrated | Illustrated |
| indexdate | 2024-12-24T08:55:35Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032855150 |
| oclc_num | 1238012219 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | IV, 179 Seiten Illustrationen, Diagramme 30 cm |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| record_format | marc |
| spellingShingle | Fricke, Mareike Ida Johanna Tumorboard- und Pathwayadhärenz am Comprehensive Cancer Center Freiburg (CCCF) eine Querschnittsstudie 2\p Tuberkulose (DE-588)4130621-1 gnd 3\p Mastdarmkrebs (DE-588)4169067-9 gnd 4\p Dickdarmkrebs (DE-588)4012122-7 gnd 5\p Krebsregister (DE-588)4123573-3 gnd 6\p Colonkrebs (DE-588)4148225-6 gnd |
| subject_GND | (DE-588)4130621-1 (DE-588)4169067-9 (DE-588)4012122-7 (DE-588)4123573-3 (DE-588)4148225-6 (DE-588)4113937-9 |
| title | Tumorboard- und Pathwayadhärenz am Comprehensive Cancer Center Freiburg (CCCF) eine Querschnittsstudie |
| title_auth | Tumorboard- und Pathwayadhärenz am Comprehensive Cancer Center Freiburg (CCCF) eine Querschnittsstudie |
| title_exact_search | Tumorboard- und Pathwayadhärenz am Comprehensive Cancer Center Freiburg (CCCF) eine Querschnittsstudie |
| title_full | Tumorboard- und Pathwayadhärenz am Comprehensive Cancer Center Freiburg (CCCF) eine Querschnittsstudie vorgelegt 2020 von Mareike Ida Johanna Fricke |
| title_fullStr | Tumorboard- und Pathwayadhärenz am Comprehensive Cancer Center Freiburg (CCCF) eine Querschnittsstudie vorgelegt 2020 von Mareike Ida Johanna Fricke |
| title_full_unstemmed | Tumorboard- und Pathwayadhärenz am Comprehensive Cancer Center Freiburg (CCCF) eine Querschnittsstudie vorgelegt 2020 von Mareike Ida Johanna Fricke |
| title_short | Tumorboard- und Pathwayadhärenz am Comprehensive Cancer Center Freiburg (CCCF) |
| title_sort | tumorboard und pathwayadharenz am comprehensive cancer center freiburg cccf eine querschnittsstudie |
| title_sub | eine Querschnittsstudie |
| topic | 2\p Tuberkulose (DE-588)4130621-1 gnd 3\p Mastdarmkrebs (DE-588)4169067-9 gnd 4\p Dickdarmkrebs (DE-588)4012122-7 gnd 5\p Krebsregister (DE-588)4123573-3 gnd 6\p Colonkrebs (DE-588)4148225-6 gnd |
| topic_facet | Tuberkulose Mastdarmkrebs Dickdarmkrebs Krebsregister Colonkrebs Hochschulschrift |
| url | https://d-nb.info/1230583319/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032855150&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT frickemareikeidajohanna tumorboardundpathwayadharenzamcomprehensivecancercenterfreiburgcccfeinequerschnittsstudie |